Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK-0752 Followed by Docetaxel in Advanced Breast Cancer
NCT00645333Phase 2Completed
- Sponsor
- University of Michigan Rogel Cancer Center
- Start
- Mar 2008
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of MK-0752 in breast cancer, sponsored by University of Michigan Rogel Cancer Center. Started Mar 2008; status: completed.
02
Drugs
MK-0752
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00645333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00645333.